WHO ICTRP trial
A randomized, open-label, single dose, two-way crossover design with two-period…
TCTR20240524006 · Thai Clinical Trials Registry (TCTR) · Not Recruiting
Key facts
| Trial ID | TCTR20240524006 |
|---|---|
| Public title | A randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence bioequivalence study of Aripiprazole Tablets 10 mg relative to Abilify (Aripiprazole Tablets 10 mg) in healthy Thai volunteers under fasting condition. |
| Scientific title | A randomized, open-label, single dose, two-way crossover design with two-period, two-treatment and two-sequence bioequivalence study of Aripiprazole Tablets 10 mg relative to Abilify (Aripiprazole Tablets 10 mg) in healthy Thai volunteers under fasting condition. |
| Primary sponsor | Bio-innova Co., Ltd. |
| Registry | Thai Clinical Trials Registry (TCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 1 |
| Countries | Thailand |
| Conditions | Healthy subjects Bioequivalence Aripiprazole Tablets 10 mg;Bioequivalence Aripiprazole Tablets 10 mg |
| Interventions | The new generic products which were recently developed. Volunteer will receive a single dose of Aripiprazole Tablets 10 mg of either test or reference with 240 mL of drinking water,The marketed original products which were already available… |
| Registration date | May 24, 2024 |
| Target size | 48 |
| Secondary IDs | Nil Known |
| Registry page | thaiclinicaltrials.org |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: